オータコイドおよび関連薬剤の世界市場レポート 2025年

オータコイドおよび関連薬剤の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.1％で、676億4,000万米ドルに成長します。予測期間中の成長は、高齢者人口の増加、慢性呼吸器疾患の有病率の増加、個別化医療の採用、新興国におけるヘルスケアアクセスの拡大、心血管障害の発生率の増加など、いくつかの要因に起因しています。この期間の主な動向としては、創薬における人工知能の統合、二重作用オータコイド医薬品の開発、オータコイド治療へのバイオシミラーの採用、セルフメディケーションと一般用医薬品（OTC）の成長、医薬品製剤におけるナノテクノロジーの利用などが挙げられます。

心血管疾患の有病率の増加は、今後数年間におけるオータコイドおよび関連薬剤市場の拡大を促進すると予想されます。心血管疾患には、冠動脈性心疾患、心不全、脳卒中、高血圧など、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。心血管疾患の増加は主に食生活の乱れに関連しており、飽和脂肪、トランス脂肪、添加糖、ナトリウムの多量摂取は、高血圧、肥満、コレステロール値の上昇の原因となっており、これらはすべて心臓に関連する疾患の重大な危険因子です。オータコイドおよび関連薬剤は、血管の緊張と炎症を調節することによって心臓血管の健康をサポートします。一酸化窒素、エンドセリン、プロスタサイクリンが関与する経路を標的とする薬剤は、内皮機能の回復、血管拡張の促進、血管抵抗の減少を助けます。例えば、2023年12月、オーストラリア保健福祉研究所（Australian Institute of Health and Welfare）は、オーストラリアにおける冠動脈性心疾患（CHD）による医師認定の死亡者数が、2021年の1万4,100人から2022年には1万4,900人に増加したと報告しました。その結果、心血管疾患の有病率の増加が、オータコイドおよび関連薬剤市場の成長に寄与しています。

自己免疫薬および関連薬市場の主要企業は、治療効果を高め、副作用を低減し、より正確かつ安全に新たなアレルギー性疾患や炎症性疾患に対処するため、抗ヒスタミン薬などの革新的な製品の開発に注力しています。抗ヒスタミン薬は、アレルギー反応の際に免疫系から放出される化学物質であるヒスタミンの作用を阻害する薬です。例えば、2023年3月、ドイツに本社を置く製薬会社Tiefenbacher Pharmaceuticalsは、ビラスチンを一般用医薬品としてドイツで発売しました。ビラスチン錠20mgは、花粉症や蕁麻疹などのアレルギー症状を持つ人に、鎮静作用のない第2世代の抗ヒスタミン剤を提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のオータコイドおよび関連薬剤のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のオータコイドおよび関連薬剤市場：成長率分析
• 世界のオータコイドおよび関連薬剤市場の実績：規模と成長、2019～2024年
• 世界のオータコイドおよび関連薬剤市場の予測：規模と成長、2024～2029年、2034年
• 世界のオータコイドおよび関連薬剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオータコイドおよび関連薬剤市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヒスタミン
• プロスタグランジン
• ロイコトリエン
• セロトニン
• ブラジキニン
• 世界のオータコイドおよび関連薬剤市場：投与方法別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 注射
• 局所
• 鼻腔内
• 吸入
• 世界のオータコイドおよび関連薬剤市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 心血管疾患
• 炎症性疾患
• 呼吸器疾患
• アレルギー
• 胃腸障害
• 世界のオータコイドおよび関連薬剤市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• ホームケア
• 薬局
• 世界のオータコイドおよび関連薬剤市場：ヒスタミンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• H1受容体拮抗薬
• H2受容体拮抗薬
• H3受容体拮抗薬
• H4受容体拮抗薬
• ヒスタミン作動薬
• 世界のオータコイドおよび関連薬剤市場：プロスタグランジンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プロスタグランジンE1（PGE1）類似体
• プロスタグランジンE2（PGE2）類似体
• プロスタグランジンF2a（PGF2a）類似体
• プロスタグランジンI2（PGI2）類似体
• プロスタグランジンD2（PGD2）類似体
• 世界のオータコイドおよび関連薬剤市場：ロイコトリエンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ロイコトリエン受容体拮抗薬（LTRA）
• 5-リポキシゲナーゼ阻害剤
• ロイコトリエン合成阻害剤
• 世界のオータコイドおよび関連薬剤市場：セロトニンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 5-HT1受容体作動薬
• 5-HT2受容体拮抗薬
• 5-HT3受容体拮抗薬
• 5-HT4受容体作動薬
• 5-HT6および5-HT7調節薬
• 世界のオータコイドおよび関連薬剤市場：ブラジキニンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ブラジキニンB1受容体拮抗薬
• ブラジキニンB2受容体拮抗薬
• ブラジキニン受容体作動薬

第7章 地域別・国別分析

• 世界のオータコイドおよび関連薬剤市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のオータコイドおよび関連薬剤市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オータコイドおよび関連薬剤市場：競合情勢
• オータコイドおよび関連薬剤市場：企業プロファイル
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
  • EUROAPI S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer CentreOne Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cayman Chemical Company
• Tokyo Chemical Industry Co. Ltd.
• Avanti Polar Lipids Inc.
• Kyowa Pharma Chemical Co. Ltd.
• Nicox S.A.
• Glentham Life Sciences Ltd.
• LGM Pharma Inc.
• chemBlink Inc.
• ZellBio GmbH
• AquigenBio LLC
• BOC Sciences Inc.
• Yarrow Chem Products Pvt. Ltd.
• LEBSA S.A.
• VDK NaturaSyn S.A.
• Enzo Life Sciences Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オータコイドおよび関連薬剤市場2029年：新たな機会を提供する国
• オータコイドおよび関連薬剤市場2029年：新たな機会を提供するセグメント
• オータコイドおよび関連薬剤市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Autacoids and related drugs are biologically active substances produced by the body that regulate physiological functions locally, typically within specific tissues or organs. They play a role in inflammation, smooth muscle contraction, immune responses, and the regulation of blood flow. Autacoids exert their effects by binding to specific receptors on target cells, triggering signaling pathways that influence cellular activity.

The main types of autacoids and related drugs include histamines, prostaglandins, leukotrienes, serotonin, and bradykinin. Histamines are chemicals released during allergic reactions that lead to symptoms such as itching, swelling, and increased stomach acid. They are targeted in treatments for allergies and acid-related conditions. Drugs aimed at these autacoids can be administered through various routes, such as oral, injectable, topical, intranasal, and inhalation. These treatments are used for a range of applications, including cardiovascular disorders, inflammatory diseases, respiratory disorders, allergies, and gastrointestinal conditions. The primary end users of these treatments include hospitals, clinics, homecare settings, and pharmacies.

The autacoids and related drug market research report is one of a series of new reports from The Business Research Company that provides autacoids and related drug market statistics, including the autacoids and related drug industry global market size, regional shares, competitors with the autacoids and related drug market share, detailed autacoids and related drug market segments, market trends, and opportunities, and any further data you may need to thrive in the autacoids and related drug industry. This autacoids and related drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The autacoids and related drug market size has grown strongly in recent years. It will grow from $50.15 billion in 2024 to $53.32 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to several factors, including the increasing prevalence of inflammatory diseases, a rising use of prostaglandins in obstetrics, widespread prescription of antihistamines, the expanding applications of serotonin agonists, and higher demand for migraine relief medications.

The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $67.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth during the forecast period can be attributed to several factors, including the rising geriatric population, growing prevalence of chronic respiratory diseases, adoption of personalized medicine, expanding healthcare access in emerging economies, and the increasing incidence of cardiovascular disorders. Key trends during this period include the integration of artificial intelligence in drug discovery, the development of dual-action autacoid drugs, the adoption of biosimilars for autacoid treatments, growth in self-medication and over-the-counter (OTC) products, and the use of nanotechnology in drug formulation.

The growing prevalence of cardiovascular diseases is expected to drive the expansion of the autacoids and related drugs market in the coming years. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. The rise in cardiovascular diseases is mainly linked to poor dietary habits, with high consumption of saturated fats, trans fats, added sugars, and sodium contributing to high blood pressure, obesity, and elevated cholesterol levels, all of which are significant risk factors for heart-related conditions. Autacoids and related drugs support cardiovascular health by modulating vascular tone and inflammation, both of which are critical in managing hypertension and heart failure. Agents that target pathways involving nitric oxide, endothelin, and prostacyclin aid in restoring endothelial function, promoting vasodilation, and reducing vascular resistance. For instance, in December 2023, the Australian Institute of Health and Welfare reported that the number of doctor-certified deaths due to coronary heart disease (CHD) in Australia rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the autacoids and related drugs market.

Leading companies in the autacoids and related drugs market are concentrating on the development of innovative products, such as antihistamines, to enhance therapeutic effectiveness, reduce side effects, and address new allergic and inflammatory conditions with greater accuracy and safety. Antihistamines are medications that block the effects of histamine, a chemical released by the immune system during an allergic reaction. For example, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceutical company, launched Bilastine as an over-the-counter (OTC) medication in Germany, representing a significant advancement in improving access to effective allergy treatments. The 20 mg Bilastine tablets offer a non-sedating, second-generation antihistamine solution for individuals experiencing allergic symptoms such as hay fever and urticaria.

In May 2024, Incyte Corporation, a US-based biopharmaceutical company, completed the acquisition of Escient Pharmaceuticals Inc. for approximately $750 million. This acquisition enables Incyte to expand its immunology portfolio and accelerate the development of novel treatments for pruritus and other inflammatory disorders by integrating Escient Pharmaceuticals' innovative pipeline of first-in-class, small molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs). Escient Pharmaceuticals Inc., a US-based biotechnology company, is focused on developing novel therapeutics that target autacoid-related pathways.

Major players in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

North America was the largest region in the autacoids and related drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in autacoids and related drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the autacoids and related drugsmarket report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The autacoids and related drug market consists of sales of biogenic amines, polypeptide autacoids, lipid-derived autacoids, and leukotrienes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autacoids And Related Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autacoids and related drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autacoids and related drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The autacoids and related drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Histamines; Prostaglandins; Leukotrienes; Serotonin; Bradykinin
• 2) By Administration: Oral; Injectable; Topical; Intranasal; Inhalation
• 3) By Application: Cardiovascular Disorders; Inflammatory Diseases; Respiratory Disorders; Allergies; Gastrointestinal Disorders
• 4) By End User: Hospitals; Clinics; Homecare; Pharmacies
• Subsegments:
• 1) By Histamines: H1 Receptor Antagonists; H2 Receptor Antagonists; H3 Receptor Antagonists; H4 Receptor Antagonists; Histamine Agonists
• 2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs; Prostaglandin E2 (PGE2) Analogs; Prostaglandin F2a (PGF2a) Analogs; Prostaglandin I2 (PGI2) Analogs; Prostaglandin D2 (PGD2) Analogs
• 3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs); 5-Lipoxygenase Inhibitors; Leukotriene Synthesis Inhibitors
• 4) By Serotonin: 5-HT1 Receptor Agonists; 5-HT2 Receptor Antagonists; 5-HT3 Receptor Antagonists; 5-HT4 Receptor Agonists; 5-HT6 And 5-HT7 Modulators
• 5) By Bradykinin: Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Bradykinin Receptor Agonists
• Companies Mentioned: Sanofi S.A.; Fresenius SE & Co. KGaA; Dr. Reddy's Laboratories Limited; EUROAPI S.A.; Pfizer CentreOne
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Autacoids And Related Drug Market Characteristics

3. Autacoids And Related Drug Market Trends And Strategies

4. Autacoids And Related Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Autacoids And Related Drug Growth Analysis And Strategic Analysis Framework

• 5.1. Global Autacoids And Related Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Autacoids And Related Drug Market Growth Rate Analysis
• 5.4. Global Autacoids And Related Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Autacoids And Related Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Autacoids And Related Drug Total Addressable Market (TAM)

6. Autacoids And Related Drug Market Segmentation

• 6.1. Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Histamines
• Prostaglandins
• Leukotrienes
• Serotonin
• Bradykinin
• 6.2. Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Topical
• Intranasal
• Inhalation
• 6.3. Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Disorders
• Inflammatory Diseases
• Respiratory Disorders
• Allergies
• Gastrointestinal Disorders
• 6.4. Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Pharmacies
• 6.5. Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• H1 Receptor Antagonists
• H2 Receptor Antagonists
• H3 Receptor Antagonists
• H4 Receptor Antagonists
• Histamine Agonists
• 6.6. Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prostaglandin E1 (PGE1) Analogs
• Prostaglandin E2 (PGE2) Analogs
• Prostaglandin F2a (PGF2a) Analogs
• Prostaglandin I2 (PGI2) Analogs
• Prostaglandin D2 (PGD2) Analogs
• 6.7. Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukotriene Receptor Antagonists (LTRAs)
• 5-Lipoxygenase Inhibitors
• Leukotriene Synthesis Inhibitors
• 6.8. Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 5-HT1 Receptor Agonists
• 5-HT2 Receptor Antagonists
• 5-HT3 Receptor Antagonists
• 5-HT4 Receptor Agonists
• 5-HT6 And 5-HT7 Modulators
• 6.9. Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bradykinin B1 Receptor Antagonists
• Bradykinin B2 Receptor Antagonists
• Bradykinin Receptor Agonists

7. Autacoids And Related Drug Market Regional And Country Analysis

• 7.1. Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Autacoids And Related Drug Market

• 8.1. Asia-Pacific Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Autacoids And Related Drug Market

• 9.1. China Autacoids And Related Drug Market Overview
• 9.2. China Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Autacoids And Related Drug Market

• 10.1. India Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Autacoids And Related Drug Market

• 11.1. Japan Autacoids And Related Drug Market Overview
• 11.2. Japan Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Autacoids And Related Drug Market

• 12.1. Australia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Autacoids And Related Drug Market

• 13.1. Indonesia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Autacoids And Related Drug Market

• 14.1. South Korea Autacoids And Related Drug Market Overview
• 14.2. South Korea Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Autacoids And Related Drug Market

• 15.1. Western Europe Autacoids And Related Drug Market Overview
• 15.2. Western Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Autacoids And Related Drug Market

• 16.1. UK Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Autacoids And Related Drug Market

• 17.1. Germany Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Autacoids And Related Drug Market

• 18.1. France Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Autacoids And Related Drug Market

• 19.1. Italy Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Autacoids And Related Drug Market

• 20.1. Spain Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Autacoids And Related Drug Market

• 21.1. Eastern Europe Autacoids And Related Drug Market Overview
• 21.2. Eastern Europe Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Autacoids And Related Drug Market

• 22.1. Russia Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Autacoids And Related Drug Market

• 23.1. North America Autacoids And Related Drug Market Overview
• 23.2. North America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Autacoids And Related Drug Market

• 24.1. USA Autacoids And Related Drug Market Overview
• 24.2. USA Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Autacoids And Related Drug Market

• 25.1. Canada Autacoids And Related Drug Market Overview
• 25.2. Canada Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Autacoids And Related Drug Market

• 26.1. South America Autacoids And Related Drug Market Overview
• 26.2. South America Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Autacoids And Related Drug Market

• 27.1. Brazil Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Autacoids And Related Drug Market

• 28.1. Middle East Autacoids And Related Drug Market Overview
• 28.2. Middle East Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Autacoids And Related Drug Market

• 29.1. Africa Autacoids And Related Drug Market Overview
• 29.2. Africa Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Autacoids And Related Drug Market Competitive Landscape And Company Profiles

• 30.1. Autacoids And Related Drug Market Competitive Landscape
• 30.2. Autacoids And Related Drug Market Company Profiles
  • 30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. EUROAPI S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Pfizer CentreOne Overview, Products and Services, Strategy and Financial Analysis

31. Autacoids And Related Drug Market Other Major And Innovative Companies

• 31.1. Cayman Chemical Company
• 31.2. Tokyo Chemical Industry Co. Ltd.
• 31.3. Avanti Polar Lipids Inc.
• 31.4. Kyowa Pharma Chemical Co. Ltd.
• 31.5. Nicox S.A.
• 31.6. Glentham Life Sciences Ltd.
• 31.7. LGM Pharma Inc.
• 31.8. chemBlink Inc.
• 31.9. ZellBio GmbH
• 31.10. AquigenBio LLC
• 31.11. BOC Sciences Inc.
• 31.12. Yarrow Chem Products Pvt. Ltd.
• 31.13. LEBSA S.A.
• 31.14. VDK NaturaSyn S.A.
• 31.15. Enzo Life Sciences Inc.

32. Global Autacoids And Related Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Autacoids And Related Drug Market

34. Recent Developments In The Autacoids And Related Drug Market

35. Autacoids And Related Drug Market High Potential Countries, Segments and Strategies

• 35.1 Autacoids And Related Drug Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Autacoids And Related Drug Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Autacoids And Related Drug Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer